Cargando…
Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815352/ http://dx.doi.org/10.1371/annotation/4afd48b1-8dc0-47cc-9c8a-99aba7623116 |
| _version_ | 1782289411024617472 |
|---|---|
| author | Moore, Andrew R. Boyce, Malcolm Steele, Islay A. Campbell, Fiona Varro, Andrea Pritchard, D. Mark |
| author_facet | Moore, Andrew R. Boyce, Malcolm Steele, Islay A. Campbell, Fiona Varro, Andrea Pritchard, D. Mark |
| author_sort | Moore, Andrew R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3815352 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-38153522013-11-09 Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis Moore, Andrew R. Boyce, Malcolm Steele, Islay A. Campbell, Fiona Varro, Andrea Pritchard, D. Mark PLoS One Correction Public Library of Science 2013-11-01 /pmc/articles/PMC3815352/ http://dx.doi.org/10.1371/annotation/4afd48b1-8dc0-47cc-9c8a-99aba7623116 Text en © 2013 Public Library of Science http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
| spellingShingle | Correction Moore, Andrew R. Boyce, Malcolm Steele, Islay A. Campbell, Fiona Varro, Andrea Pritchard, D. Mark Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis |
| title | Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis |
| title_full | Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis |
| title_fullStr | Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis |
| title_full_unstemmed | Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis |
| title_short | Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis |
| title_sort | correction: netazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chronic atrophic gastritis |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815352/ http://dx.doi.org/10.1371/annotation/4afd48b1-8dc0-47cc-9c8a-99aba7623116 |
| work_keys_str_mv | AT mooreandrewr correctionnetazepideagastrinreceptorantagonistnormalisestumourbiomarkersandcausesregressionoftype1gastricneuroendocrinetumoursinanonrandomisedtrialofpatientswithchronicatrophicgastritis AT boycemalcolm correctionnetazepideagastrinreceptorantagonistnormalisestumourbiomarkersandcausesregressionoftype1gastricneuroendocrinetumoursinanonrandomisedtrialofpatientswithchronicatrophicgastritis AT steeleislaya correctionnetazepideagastrinreceptorantagonistnormalisestumourbiomarkersandcausesregressionoftype1gastricneuroendocrinetumoursinanonrandomisedtrialofpatientswithchronicatrophicgastritis AT campbellfiona correctionnetazepideagastrinreceptorantagonistnormalisestumourbiomarkersandcausesregressionoftype1gastricneuroendocrinetumoursinanonrandomisedtrialofpatientswithchronicatrophicgastritis AT varroandrea correctionnetazepideagastrinreceptorantagonistnormalisestumourbiomarkersandcausesregressionoftype1gastricneuroendocrinetumoursinanonrandomisedtrialofpatientswithchronicatrophicgastritis AT pritcharddmark correctionnetazepideagastrinreceptorantagonistnormalisestumourbiomarkersandcausesregressionoftype1gastricneuroendocrinetumoursinanonrandomisedtrialofpatientswithchronicatrophicgastritis |